BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 25674261)

  • 41. Downregulation of long noncoding RNA ZMAT1 transcript variant 2 predicts a poor prognosis in patients with gastric cancer.
    Lai Y; Xu P; Li Q; Ren D; Wang J; Xu K; Gao W
    Int J Clin Exp Pathol; 2015; 8(5):5556-62. PubMed ID: 26191264
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The up-regulation of long non-coding RNA AFAP1-AS1 is associated with the poor prognosis of NSCLC patients.
    Deng J; Liang Y; Liu C; He S; Wang S
    Biomed Pharmacother; 2015 Oct; 75():8-11. PubMed ID: 26463625
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Down-regulation of ncRAN, a long non-coding RNA, contributes to colorectal cancer cell migration and invasion and predicts poor overall survival for colorectal cancer patients.
    Qi P; Xu MD; Ni SJ; Shen XH; Wei P; Huang D; Tan C; Sheng WQ; Zhou XY; Du X
    Mol Carcinog; 2015 Sep; 54(9):742-50. PubMed ID: 24519959
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aberrant expression of UCA1 in gastric cancer and its clinical significance.
    Zheng Q; Wu F; Dai WY; Zheng DC; Zheng C; Ye H; Zhou B; Chen JJ; Chen P
    Clin Transl Oncol; 2015 Aug; 17(8):640-6. PubMed ID: 25903045
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Downregulation of microRNA-206 is a potent prognostic marker for patients with gastric cancer.
    Yang Q; Zhang C; Huang B; Li H; Zhang R; Huang Y; Wang J
    Eur J Gastroenterol Hepatol; 2013 Aug; 25(8):953-7. PubMed ID: 23751352
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Up-regulation of long non-coding RNA PCAT-1 correlates with tumor progression and poor prognosis in gastric cancer.
    Cui WC; Wu YF; Qu HM
    Eur Rev Med Pharmacol Sci; 2017 Jul; 21(13):3021-3027. PubMed ID: 28742205
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long non-coding RNA HOTTIP is up-regulated and associated with poor prognosis in patients with osteosarcoma.
    Li F; Cao L; Hang D; Wang F; Wang Q
    Int J Clin Exp Pathol; 2015; 8(9):11414-20. PubMed ID: 26617868
    [TBL] [Abstract][Full Text] [Related]  

  • 48. LncRNA CADM1-AS1 serves as a new prognostic biomarker for gastric cancer.
    Shi XY; Sun YZ; Li M; Li HY
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):232-238. PubMed ID: 31389606
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High expression of long non-coding RNA ATB indicates a poor prognosis and regulates cell proliferation and metastasis in non-small cell lung cancer.
    Ke L; Xu SB; Wang J; Jiang XL; Xu MQ
    Clin Transl Oncol; 2017 May; 19(5):599-605. PubMed ID: 27878433
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Overexpression of lncRNA LINC01793 acts as a potential predictor for progression and poor prognosis of gastric cancer.
    Huang S; Chen L
    Histol Histopathol; 2019 Mar; 34(3):233-239. PubMed ID: 29978448
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased expression of LncRNA PANDAR predicts a poor prognosis in gastric cancer.
    Ma P; Xu T; Huang M; Shu Y
    Biomed Pharmacother; 2016 Mar; 78():172-176. PubMed ID: 26898439
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long noncoding RNA FEZF1-AS1 indicates a poor prognosis of gastric cancer and promotes tumorigenesis via activation of Wnt signaling pathway.
    Wu X; Zhang P; Zhu H; Li S; Chen X; Shi L
    Biomed Pharmacother; 2017 Dec; 96():1103-1108. PubMed ID: 29239821
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Upregulated expression of long noncoding RNA SNHG15 promotes cell proliferation and invasion through regulates MMP2/MMP9 in patients with GC.
    Chen SX; Yin JF; Lin BC; Su HF; Zheng Z; Xie CY; Fei ZH
    Tumour Biol; 2016 May; 37(5):6801-12. PubMed ID: 26662309
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aberrant expression of long noncoding RNAs in colorectal cancer with liver metastasis.
    Ye LC; Ren L; Qiu JJ; Zhu DX; Chen T; Chang WJ; Lv SX; Xu J
    Tumour Biol; 2015 Nov; 36(11):8747-54. PubMed ID: 26050227
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increased expression of the lncRNA PVT1 is associated with poor prognosis in pancreatic cancer patients.
    Huang C; Yu W; Wang Q; Cui H; Wang Y; Zhang L; Han F; Huang T
    Minerva Med; 2015 Jun; 106(3):143-9. PubMed ID: 25668599
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic value of miR-141 downregulation in gastric cancer.
    Lu YB; Hu JJ; Sun WJ; Duan XH; Chen X
    Genet Mol Res; 2015 Dec; 14(4):17305-11. PubMed ID: 26681225
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance.
    Hashiguchi Y; Nishida N; Mimori K; Sudo T; Tanaka F; Shibata K; Ishii H; Mochizuki H; Hase K; Doki Y; Mori M
    Int J Oncol; 2012 May; 40(5):1477-82. PubMed ID: 22322911
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The up-regulation of long non-coding RNA CCAT2 indicates a poor prognosis for prostate cancer and promotes metastasis by affecting epithelial-mesenchymal transition.
    Zheng J; Zhao S; He X; Zheng Z; Bai W; Duan Y; Cheng S; Wang J; Liu X; Zhang G
    Biochem Biophys Res Commun; 2016 Nov; 480(4):508-514. PubMed ID: 27558961
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Down-regulation of C/EBP homologous protein (CHOP) expression in gastric cardia adenocarcinoma: Their relationship with clinicopathological parameters and prognostic significance.
    Zhu XJ; Gao SG; Li SQ; Shi ZG; Ma ZK; Zhu SS; Feng XS
    Clin Res Hepatol Gastroenterol; 2015 Jun; 39(3):391-8. PubMed ID: 25582300
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased Expression of Long Non-Coding RNA BCAR4 Is Predictive of Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
    Gong J; Zhang H; He L; Wang L; Wang J
    Tohoku J Exp Med; 2017 Jan; 241(1):29-34. PubMed ID: 28077810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.